CClinicalTrials.gg
CompletedNCT03536702Updated Oct 20, 2020Results posted

Effect of Group Led Creative Writing on Mood in Cancer Patients

An interventional study of Creative Writing Workshop and Independent Writing - Control Group in Cancer Patients, sponsored by Milton S. Hershey Medical Center. Completed at 1 site in United States. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2020-10-20.

Sponsored by Milton S. Hershey Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

The primary purpose of this study is to determine whether creative writing in newly diagnosed cancer patients and those with recent progression in their disease will have a positive impact on their mental health. Using a randomized controlled trial approach, emotion thermometers will be employed to evaluate participants' responses on a number of domains, such as anxiety, depression, despair, and anger along with a series of survey questions to monitor changes in depressive and anxiety symptoms. Open-ended survey questions will be used to capture how a creative writing intervention impacts participants' experience of their illness. Melissa Greene's Write from the Heart program focuses more on creative writing rather than cancer focused topics. Patients in the intervention arm will complete -one and a half hour group sessions every two weeks over the span of 3 months. Participants in the active control arm will be provided a book (i.e., Writing Down Bones by Natalie Goldberg) about creative writing and will be asked to do activities for 1.5 hrs every 2 weeks for a period of 3 months.

Read the detailed description

Mental wellness before and after intervention in both arms. A validated Emotional Thermometer Scales will be used to predict changes in parameters reflecting participants' mental health pre- and post-intervention. Survey questions focused on symptoms of depression and anxiety will be used to monitor for changes in mental wellness pre- and post-intervention.

02

Conditions studied

  • Cancer Patients
03

In context

Lead sponsor

Milton S. Hershey Medical Center is the lead sponsor of 480 studies on the registry; 61 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 42 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Newly diagnosed with any stage or type of cancer within 3 months OR progression of disease within 3 months of enrollment. Recurrence of cancer within 3 months of enrollment would also be eligible as it will be considered as progression of cancer Ability to understand English language and ability to write without any functional difficulty ECOG performance status 0-3

Exclusion criteria

Exclusion Criteria:

Inability to give informed consent Severe psychiatry illness (e.g., uncontrolled depression, schizophrenia or psychosis) Severe cognitive impairment Pregnant females Inability to write or understand English

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Creative Writing Workshop

    The intervention arm will receive a dedicated workshop for one and a half hours every 2 weeks for 3 months.

    Other: Creative Writing Workshop

  • Active comparator
    Independent Writing - Control Group

    The control arm will receive a book (i.e., Writing Down Bones by Natalie Goldberg) on creative writing and asked to read and do writing activities for one and a half hours once every two weeks for 3 months.

    Other: Independent Writing - Control Group

Interventions

  • OtherCreative Writing Workshop

    This group will participate in a writing workshop in group sessions.

  • OtherIndependent Writing - Control Group

    This group will receive a book for a self writing session.

06

What researchers measure

Primary outcomes

  1. Emotional Thermometer Subscale 1- Distress at Final

    Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.

    Time frame: 4 months

  2. Emotional Thermometer Subscale 2 - Anxiety at Final

    Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.

    Time frame: 4 months

  3. Emotional Thermometer Subscale 3 - Depression at Final

    Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.re.

    Time frame: 4 months

  4. Emotional Thermometer Subscale 4-anger at Final

    Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score..

    Time frame: 4 months

  5. Emotional Thermometer Subscale 5-need Help at Final

    Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.

    Time frame: 4 months

  6. Emotional Thermometer Score (Total) at Final

    Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.score.

    Time frame: 4 months

Secondary outcomes

  1. Depression Symptoms

    Severity of depression symptoms before and after intervention between two groups. The validated depression questionnaire, the Patient Health Questionnaire-9 (PHQ-9), will be used to predict changes. This questionnaire includes 9 questions, that describes individual symptoms of depression and asks individuals to asses how much each depression symptoms has bothered them in the last two weeks, from 0 (not at all) to 3 (nearly every day). The total score is compiled to represent a final depression severity score, with higher scores indicating worse severity, at a maximum value of 27 points.

    Time frame: 4 months

  2. Anxiety Symptoms

    Severity of anxiety symptoms before and after intervention between two groups. The validated anxiety questionnaire, the Generalized Anxiety Disorder - 7 Scale, will be used to predict changes. This includes 7 questions describing symptoms of generalized anxiety, asking individual patients to rate how much those symptoms have bothered the individual in the past two weeks, from a score of 0 (not at all) to 3 (nearly every day). The total of the scores will be used to represent anxiety symptoms score, with a minimum score of 0 and a maximum score of 21, with higher score representing increasing severity of anxiety.

    Time frame: 4 months

  3. Self Reported Somatic Symptoms at Final

    Self-reported somatic symptoms pre and post intervention in two groups. We will use the Somatic Symptom Scale - 8 (SSS-8) to quantify somatic symptom burden. The scale is composed of 8 questions with options to choose a score of 0 (not at all) - 4 (very much) to describe degree of distress caused by individual somatic symptoms. A total of the 8 scores is used as a final value for the SSS-8, with higher scores indicating worse Somatic Symptom severity.

    Time frame: 4 months

  4. Depression Symptoms at Final

    Severity of depression symptoms before and after intervention between two groups. The validated depression questionnaire, the Patient Health Questionnaire-9 (PHQ-9), will be used to predict changes. This questionnaire includes 9 questions, that describes individual symptoms of depression and asks individuals to asses how much each depression symptoms has bothered them in the last two weeks, from 0 (not at all) to 3 (nearly every day). The total score is compiled to represent a final depression severity score, with higher scores indicating worse severity, at a maximum value of 27 points

    Time frame: 4 months

Other outcomes

  1. Status of Cancer at Consent

    Comparison of status of cancer (stable, progressing, in remission) between intervention and control group.

    Time frame: consent

  2. Number of Subjects Who Were Admitted to the Hospital and ER Admissions During Study Time

    Difference in number of emergency room visits and hospitalizations during study period between control and intervention group

    Time frame: 4 months

  3. Number of Subject That Were Not Hospital or ER Admissions After Study

    Difference in number of emergency room visits and hospitalizations during study period between control and intervention group

    Time frame: 4 months

  4. Number of Emergency Room Visits and Hospitalizations Per Subject

    Difference in number of emergency room visits and hospitalizations per subject during study period between control and intervention group

    Time frame: 4 months

  5. Status of Cancer at End of Study

    Comparison of status of cancer (stable, progressing, in remission) between intervention and control group.

    Time frame: 4 months

  6. Number of Subject That Were Not Hospitalized or in the Emergency Room During Study Time

    Difference in number of emergency room visits and hospitalizations by subject during study period between control and intervention group

    Time frame: 4 months

07

Results

Posted Oct 20, 2020

Participant flow

Participant flow — Overall Study
MilestoneCreative Writing WorkshopIndependent Writing - Control Group
Started4020
Completed268
Not completed1412

Outcome measures

PrimaryEmotional Thermometer Subscale 1- Distress at Final

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.

Time frame:
4 months
Reported as:
Median · units on a scale
Emotional Thermometer Subscale 1- Distress at Final
units on a scaleCreative Writing WorkshopIndependent Writing - Control Group
Emotional Thermometer Subscale 1- Distress at Final0 (0 to 4)1.5 (0 to 4.5)
PrimaryEmotional Thermometer Subscale 2 - Anxiety at Final

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.

Time frame:
4 months
Reported as:
Median · units on a scale
Emotional Thermometer Subscale 2 - Anxiety at Final
units on a scaleCreative Writing WorkshopIndependent Writing - Control Group
Emotional Thermometer Subscale 2 - Anxiety at Final1 (0 to 6)2.5 (1 to 7)
PrimaryEmotional Thermometer Subscale 3 - Depression at Final

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.re.

Time frame:
4 months
Reported as:
Median · units on a scale
Emotional Thermometer Subscale 3 - Depression at Final
units on a scaleCreative Writing WorkshopIndependent Writing - Control Group
Emotional Thermometer Subscale 3 - Depression at Final0 (0 to 6)2 (0 to 7)
PrimaryEmotional Thermometer Subscale 4-anger at Final

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score..

Time frame:
4 months
Reported as:
Median · units on a scale
Emotional Thermometer Subscale 4-anger at Final
units on a scaleCreative Writing WorkshopIndependent Writing - Control Group
Emotional Thermometer Subscale 4-anger at Final0 (0 to 4)1.5 (0 to 5)
PrimaryEmotional Thermometer Subscale 5-need Help at Final

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.

Time frame:
4 months
Reported as:
Median · units on a scale
Emotional Thermometer Subscale 5-need Help at Final
units on a scaleCreative Writing WorkshopIndependent Writing - Control Group
Emotional Thermometer Subscale 5-need Help at Final0 (0 to 6)0.5 (0 to 3)
PrimaryEmotional Thermometer Score (Total) at Final

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.score.

Time frame:
4 months
Reported as:
Median · units on a scale
Emotional Thermometer Score (Total) at Final
units on a scaleCreative Writing WorkshopIndependent Writing - Control Group
Emotional Thermometer Score (Total) at Final2 (0 to 25)9.5 (2 to 21)
SecondaryDepression Symptoms

Severity of depression symptoms before and after intervention between two groups. The validated depression questionnaire, the Patient Health Questionnaire-9 (PHQ-9), will be used to predict changes. This questionnaire includes 9 questions, that describes individual symptoms of depression and asks individuals to asses how much each depression symptoms has bothered them in the last two weeks, from 0 (not at all) to 3 (nearly every day). The total score is compiled to represent a final depression severity score, with higher scores indicating worse severity, at a maximum value of 27 points.

Time frame:
4 months
Reported as:
Median · units on a scale
Depression Symptoms
units on a scaleCreative Writing WorkshopIndependent Writing - Control Group
Depression Symptoms3 (0 to 18)3 (1 to 16)
SecondaryAnxiety Symptoms

Severity of anxiety symptoms before and after intervention between two groups. The validated anxiety questionnaire, the Generalized Anxiety Disorder - 7 Scale, will be used to predict changes. This includes 7 questions describing symptoms of generalized anxiety, asking individual patients to rate how much those symptoms have bothered the individual in the past two weeks, from a score of 0 (not at all) to 3 (nearly every day). The total of the scores will be used to represent anxiety symptoms score, with a minimum score of 0 and a maximum score of 21, with higher score representing increasing severity of anxiety.

Time frame:
4 months

Results for this outcome have not been posted.

SecondarySelf Reported Somatic Symptoms at Final

Self-reported somatic symptoms pre and post intervention in two groups. We will use the Somatic Symptom Scale - 8 (SSS-8) to quantify somatic symptom burden. The scale is composed of 8 questions with options to choose a score of 0 (not at all) - 4 (very much) to describe degree of distress caused by individual somatic symptoms. A total of the 8 scores is used as a final value for the SSS-8, with higher scores indicating worse Somatic Symptom severity.

Time frame:
4 months
Reported as:
Median · units on a scale
Self Reported Somatic Symptoms at Final
units on a scaleCreative Writing WorkshopIndependent Writing - Control Group
Self Reported Somatic Symptoms at Final7 (1 to 16)5 (1 to 20)
SecondaryDepression Symptoms at Final

Severity of depression symptoms before and after intervention between two groups. The validated depression questionnaire, the Patient Health Questionnaire-9 (PHQ-9), will be used to predict changes. This questionnaire includes 9 questions, that describes individual symptoms of depression and asks individuals to asses how much each depression symptoms has bothered them in the last two weeks, from 0 (not at all) to 3 (nearly every day). The total score is compiled to represent a final depression severity score, with higher scores indicating worse severity, at a maximum value of 27 points

Time frame:
4 months
Reported as:
Median · units on a scale
Depression Symptoms at Final
units on a scaleCreative Writing WorkshopIndependent Writing - Control Group
Depression Symptoms at Final3 (0 to 18)3 (1 to 16)
Other pre-specifiedStatus of Cancer at Consent

Comparison of status of cancer (stable, progressing, in remission) between intervention and control group.

Time frame:
consent
Reported as:
Count of participants · Participants
Status of Cancer at Consent
ParticipantsCreative Writing WorkshopIndependent Writing - Control Group
Cured21
New102
Progression50
Stable95
Other pre-specifiedNumber of Subjects Who Were Admitted to the Hospital and ER Admissions During Study Time

Difference in number of emergency room visits and hospitalizations during study period between control and intervention group

Time frame:
4 months
Reported as:
Count of participants · Participants
Number of Subjects Who Were Admitted to the Hospital and ER Admissions During Study Time
ParticipantsCreative Writing WorkshopIndependent Writing - Control Group
Number of Subjects Who Were Admitted to the Hospital and ER Admissions During Study Time50
Other pre-specifiedNumber of Subject That Were Not Hospital or ER Admissions After Study

Difference in number of emergency room visits and hospitalizations during study period between control and intervention group

Time frame:
4 months
Reported as:
Count of participants · Participants
Number of Subject That Were Not Hospital or ER Admissions After Study
ParticipantsCreative Writing WorkshopIndependent Writing - Control Group
Number of Subject That Were Not Hospital or ER Admissions After Study204
Other pre-specifiedNumber of Emergency Room Visits and Hospitalizations Per Subject

Difference in number of emergency room visits and hospitalizations per subject during study period between control and intervention group

Time frame:
4 months
Reported as:
Number · ER visits and hospitalizations
Number of Emergency Room Visits and Hospitalizations Per Subject
ER visits and hospitalizationsCreative Writing WorkshopIndependent Writing - Control Group
Number of Emergency Room Visits and Hospitalizations Per Subject64
Other pre-specifiedStatus of Cancer at End of Study

Comparison of status of cancer (stable, progressing, in remission) between intervention and control group.

Time frame:
4 months
Reported as:
Count of participants · Participants
Status of Cancer at End of Study
ParticipantsCreative Writing WorkshopIndependent Writing - Control Group
stable185
Progression83
Other pre-specifiedNumber of Subject That Were Not Hospitalized or in the Emergency Room During Study Time

Difference in number of emergency room visits and hospitalizations by subject during study period between control and intervention group

Time frame:
4 months
Reported as:
Count of participants · Participants
Number of Subject That Were Not Hospitalized or in the Emergency Room During Study Time
ParticipantsCreative Writing WorkshopIndependent Writing - Control Group
Number of Subject That Were Not Hospitalized or in the Emergency Room During Study Time218

Adverse events

Collected over up to 4 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Creative Writing Workshop0/26 (0%)0/26 (0%)0/26 (0%)
Independent Writing - Control Group0/8 (0%)0/8 (0%)0/8 (0%)

Baseline characteristics

Following the Intention-to-treat (ITT) principle, we report the status of all the 60 consented participants, who have been randomized with 1:2 ratio to two groups (control and intervention). Of those 60, 34 completed the baseline measures and took one class.

Age, Continuous
Age, Continuous(years)Creative Writing WorkshopIndependent Writing - Control GroupTotal
Mean63.2 ± 10.857.8 ± 10.161.9 ± 10.8
Sex: Female, Male
Sex: Female, Male(Participants)Creative Writing WorkshopIndependent Writing - Control GroupTotal
Female18422
Male8412
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Creative Writing WorkshopIndependent Writing - Control GroupTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American112
White25732
More than one race000
Unknown or Not Reported000
Mood Score Baseline Emotional Thermometer Scale subscale 1-distress
Mood Score Baseline Emotional Thermometer Scale subscale 1-distress(units on a scale)Creative Writing WorkshopIndependent Writing - Control GroupTotal
Median2 (0 to 6.5)2 (0 to 5)2 (0 to 6.5)
Emotional Thermometer subscale 2- anxiety baseline
Emotional Thermometer subscale 2- anxiety baseline(units on a scale)Creative Writing WorkshopIndependent Writing - Control GroupTotal
Median4 (0 to 10)5.5 (1 to 8)4 (0 to 10)
Emotional Thermometer subscale 3- depression baseline
Emotional Thermometer subscale 3- depression baseline(units on a scale)Creative Writing WorkshopIndependent Writing - Control GroupTotal
Median1 (0 to 9)3 (0 to 8)1.2 (0 to 9)
Emotional Thermometer subscale 4- anger baseline
Emotional Thermometer subscale 4- anger baseline(units on a scale)Creative Writing WorkshopIndependent Writing - Control GroupTotal
Median0.2 (0 to 7)2.5 (0 to 10)0.5 (0 to 10)
Emotional Thermometer subscale 5- need help baseline
Emotional Thermometer subscale 5- need help baseline(units on a scale)Creative Writing WorkshopIndependent Writing - Control GroupTotal
Median1 (0 to 7)1.5 (0 to 8)1 (0 to 8)

4 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Penn State Cancer Institute
    Hershey, Pennsylvania 17033, United States
09

References and documents

Publications

  • DOI: 10.1200/JCO.2017.35.31_suppl.178 Journal of Clinical Oncology 35, no. 31_suppl (November 2017) 178-178.

Study documents

  • Protocol and statistical analysis plan · Jan 24, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 20, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03536702
Lead sponsor
Milton S. Hershey Medical Center
Responsible party
Monika Joshi (Assistant Professor, Department of Medicine, Division of Hematology-Oncology, Milton S. Hershey Medical Center) — Principal investigator
First posted
May 25, 2018
Start date
Mar 28, 2018
Primary completion
Nov 16, 2018
Completion
Nov 16, 2018
Results posted
Oct 20, 2020
Last update
Oct 20, 2020

Study contacts

Monika Joshi, MD
principal investigator · Penn State Hershey Cancer Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion